SIBILLE, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 97
EU - Europa 89
AS - Asia 25
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 214
Nazione #
US - Stati Uniti d'America 97
IT - Italia 49
IE - Irlanda 14
SE - Svezia 11
CN - Cina 9
FR - Francia 6
VN - Vietnam 6
HK - Hong Kong 4
SG - Singapore 4
UA - Ucraina 4
DK - Danimarca 2
EU - Europa 2
PL - Polonia 2
BR - Brasile 1
GB - Regno Unito 1
IN - India 1
KR - Corea 1
Totale 214
Città #
Torino 16
Dublin 14
Turin 11
Chandler 9
Fairfield 8
Houston 8
Ashburn 7
Nyköping 7
Cambridge 4
Dong Ket 4
Medford 4
Pisa 4
Senago 4
Hangzhou 3
Princeton 3
Seattle 3
Singapore 3
Boston 2
Copenhagen 2
Guiyang 2
Jacksonville 2
Warsaw 2
Wilmington 2
Ann Arbor 1
Beijing 1
Central District 1
Dearborn 1
Grugliasco 1
Haikou 1
Kunming 1
Novara 1
Piemonte 1
Recife 1
Rome 1
San Diego 1
San Francisco 1
Seoul 1
Shenzhen 1
Woodbridge 1
Yurovka 1
Totale 141
Nome #
Zoledronic Acid and Leuprolide Acetate Affect Du-145 Migration towards Stem Cell Conditioned Medium 79
Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication 70
The new generation hdhodh inhibitor meds433 hinders the in vitro replication of sars-cov-2 and other human coronaviruses [Calistri A.*, Luganini A.*, co-first author] 49
The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis 13
Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication 10
Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 Mpro 6
Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses 3
Totale 230
Categoria #
all - tutte 951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 4 2
2019/202013 0 1 1 1 1 1 1 3 2 0 2 0
2020/202128 1 0 2 0 0 2 0 0 6 2 5 10
2021/202260 1 0 13 7 3 1 4 2 0 6 12 11
2022/202364 4 6 1 2 6 15 6 7 5 0 10 2
2023/202439 4 5 5 5 4 6 0 1 2 3 4 0
Totale 230